E-LIB Suche - Ergebnisse für: Marchion, Douglas C.

1

Detectable Lipidomes and Metabolomes by Different Plasma Ex..:

Soupir, Alex C. ; Tian, Yijun ; Stewart, Paul A....
International Journal of Molecular Sciences. 24 (2023) 3 - p. 1830 , 2023

Link: https://doi.org/10.3390/..

2

Prevalence of viral DNA in high-grade serous epithelial ova..:

Robertson, Sharon E. ; Yasukawa, Maya ; Marchion, Douglas C....
PLOS ONE. 18 (2023) 12 - p. e0294448 , 2023

Link: https://doi.org/10.1371/..

3

Utilizing digital pathology to quantify stromal caveolin-1 ..:

Saeed-Vafa, Daryoush ; Marchion, Douglas C. ; McCarthy, Susan M....
PLOS ONE. 16 (2021) 11 - p. e0256615 , 2021

Link: https://doi.org/10.1371/..

4

Pan-cancer analysis reveals TAp63-regulated oncogenic lncRN..:

Napoli, Marco ; Li, Xiaobo ; Ackerman, Hayley D....
Nature Communications. 11 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

5

Expression of the BAD pathway is a marker of triple-negativ..:

Boac, Bernadette M. ; Abbasi, Forough ; Ismail-Khan, Roohi...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

6

ERBB4 Expression in Ovarian Serous Carcinoma Resistant to P..:

Saglam, Ozlen ; Xiong, Yin ; Marchion, Douglas C....
Cancer Control. 24 (2017) 1 - p. 89-95 , 2017

Link: https://doi.org/10.1177/..

7

Micro-RNAs associated with the evolution of ovarian cancer ..:

Boac, Bernadette M. ; Xiong, Yin ; Marchion, Douglas C....
Gynecologic Oncology. 140 (2016) 2 - p. 259-263 , 2016

Link: https://doi.org/10.1016/..

8

The Chinese herb polyphyllin D sensitizes ovarian cancer ce..:

Sawah, Entidhar Al ; Marchion, Douglas C. ; Xiong, Yin...
Journal of Cancer Research and Clinical Oncology. 141 (2014) 2 - p. 237-242 , 2014

Link: https://doi.org/10.1007/..

9

Gene expression data reveal common pathways that characteri..:

Marchion, Douglas C. ; Xiong, Yin ; Chon, Hye Sook...
American Journal of Obstetrics and Gynecology. 209 (2013) 6 - p. 576.e1-576.e16 , 2013

Link: https://doi.org/10.1016/..

10

Perifosine, an AKT inhibitor, modulates ovarian cancer cell..:

Al Sawah, Entidhar ; Chen, Xin ; Marchion, Douglas C....
Gynecologic Oncology. 131 (2013) 1 - p. 207-212 , 2013

Link: https://doi.org/10.1016/..

11

BCL2 antagonist of cell death kinases, phosphatases, and ov..:

Bansal, Nisha ; Marchion, Douglas C. ; Bicaku, Elona...
Journal of Gynecologic Oncology. 23 (2012) 1 - p. 35 , 2012

Link: https://doi.org/10.3802/..

12

The BCL2 antagonist of cell death pathway influences endome..:

Chon, Hye Sook ; Marchion, Douglas C. ; Xiong, Yin...
Gynecologic Oncology. 124 (2012) 1 - p. 119-124 , 2012

Link: https://doi.org/10.1016/..

13

Addition of a histone deacetylase inhibitor redirects tamox..:

Thomas, Scott ; Thurn, Kenneth T. ; Biçaku, Elona..
Breast Cancer Research and Treatment. 130 (2011) 2 - p. 437-447 , 2011

Link: https://doi.org/10.1007/..

14

Sequence‐specific potentiation of topoisomerase II inhibito..:

Marchion, Douglas C. ; Bicaku, Elona ; Daud, Adil I....
Journal of Cellular Biochemistry. 92 (2004) 2 - p. 223-237 , 2004

Link: https://doi.org/10.1002/..

15

An in vitro model of pericardial tissue healing:

Marchion, Douglas C ; Pfau, Jean C ; Weber, Patricia A...
Biomaterials. 24 (2003) 1 - p. 89-95 , 2003

Link: https://doi.org/10.1016/..